Evaxion A (EVAX) Receivables - Net (2019 - 2025)

Evaxion A (EVAX) posted Receivables - Net of $424000.0 for Q2 2025, up 8.16% on a QoQ basis from $392000.0 in Q2 2024, and up 8.16% year-over-year from $392000.0 in Q2 2024.

Evaxion A (EVAX) Receivables - Net (2019 - 2025) Analysis & Trends

Evaxion A's Receivables - Net history runs 7 years deep, the most recent figure standing at $424000.0 for Q2 2025.

  • Quarterly Receivables - Net rose 8.16% year-over-year to $424000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $424000.0 (up 8.16% YoY) and the FY2023 annual result came in at $2.0 million, down 30.06% from the prior year.
  • Receivables - Net was $424000.0 for Q2 2025 at Evaxion A, up from $392000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $2.8 million in Q4 2022 and bottomed at $245000.0 in Q1 2022.
  • A 5-year average of $781444.4 and a median of $425000.0 in 2023 frame the typical range for Receivables - Net.
  • Peak annual rise in Receivables - Net reached 145.25% in 2022, while the deepest fall reached 26.96% in 2022.
  • Evaxion A's Receivables - Net stood at $1.1 million in 2021, then jumped by 145.25% to $2.8 million in 2022, then slumped by 84.77% to $425000.0 in 2023, then retreated by 7.76% to $392000.0 in 2024, then grew by 8.16% to $424000.0 in 2025.
  • Business Quant data shows EVAX's Receivables - Net at $424000.0 in Q2 2025, $392000.0 in Q2 2024, and $425000.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Evaxion A 1.23 Bn 1.23 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2025 424,000.00
Jun 30, 2025 424,000.00
Jun 30, 2024 392,000.00
Jun 30, 2024 392,000.00
Jun 30, 2023 425,000.00
Jun 30, 2023 425,000.00
Dec 31, 2022 2.79 Mn
Dec 31, 2022 2.79 Mn
Jun 30, 2022 401,000.00
Jun 30, 2022 401,000.00
Mar 31, 2022 245,000.00
Mar 31, 2022 245,000.00
Dec 31, 2021 1.14 Mn
Dec 31, 2021 1.14 Mn
Sep 30, 2021 668,000.00
Sep 30, 2021 668,000.00
Jun 30, 2021 549,000.00
Jun 30, 2021 549,000.00
Dec 31, 2020 1.55 Mn
Dec 31, 2020 1.55 Mn